Peptides & SARMs
Unapproved research peptides such as BPC-157, SARMs such as ostarine and RAD-140, and MK-677.
Don't stop, replace, or delay any treatment without talking to your doctor.
Peptides & SARMs · 2025-12-11 · Guardian Australia (independent journalism), December 11, 2025
"All allowed us to immediately browse and 'add to cart' injectable peptides that have not been approved by the TGA ... before speaking with a medical practitioner." It describes BPC-157 as having "been investigated for w…
Peptides & SARMs · 2025-09-01 · Edwin Lee, MD & Kailynd Burgess, Alternative Therapies in Health and Medicine, 2025
"The infusions of BPC-157 resulted in no measurable effects on the tested biomarkers of the heart, liver, kidneys, thyroid, or blood glucose levels ... with no side effects reported."…
Peptides & SARMs · 2024-03-29 · Evexias Medical Centers et al. v. FDA, No. 4:24-cv-00293 (N.D. Tex., filed Mar. 29, 2024); Alliance for Pharmacy Compounding news, Sept 2024
Plaintiffs argued the peptides were moved without advisory-committee review or notice-and-comment. A settlement led to advisory committee meetings in October and December 2024 to review four peptides.…
Peptides & SARMs · 2021-07-01 · Edwin Lee, MD & Bradley Padgett, Alternative Therapies in Health and Medicine, 2021
"Of the 16 patients, 12 had received only BPC 157 ... 11 of the 12 patients (91.6%) had significant improvement in knee pain." "Overall, 14 of 16 patients (87.5%) had relief of their knee pain."…
Peptides & SARMs · 2013-08-19 · GTx, Inc. press release (Business Wire), Aug 19, 2013, via Fierce Biotech
The trials "failed to meet the overall criteria for the co-primary responder endpoints of lean body mass and physical function." An exploratory analysis showed a "consistent effect on LBM" in both trials; stair-climb res…
Peptides & SARMs · 2011-08-02 · Dalton et al. (GTx, Inc.), Journal of Cachexia, Sarcopenia and Muscle, 2011
At 3 mg, participants gained "a statistically significant (P < 0.001) average of 1.3 kg" of lean mass versus placebo, with improved stair-climb power (P = 0.013). "No SAEs were reported."…
Peptides & SARMs · 2010-11-09 · Adunsky et al., Archives of Gerontology and Geriatrics 53(2):183-9, 2011 (Merck-sponsored)
IGF-1 rose by 51.4 ng/ml versus placebo; gait speed improved (p = 0.011) and there were fewer falls (p = 0.096, not significant).…
Paper Trail Health summarizes published studies, case reports, court filings and journalism for general information. It is not medical, legal or investment advice. Summaries quote the sources; a source's statements are its authors', not findings of this site. Don't stop, replace, or delay treatment without your doctor. Always read the linked original. See
Standards & corrections and
Disclaimer.